Phase I studies of darinaparsin in patients with relapsed or refractory peripheral T-cell lymphoma: a pooled analysis of two phase I studies conducted in Japan and Korea

por Ogura, Michinori, Kim, Won-Seog, Uchida, Toshiki, Uike, Naokuni, Suehiro, Youko, Ishizawa, Kenichi, Nagai, Hirokazu, Nagahama, Fumiko, Sonehara, Yusuke, Tobinai, Kensei
Publicado 2020

Darinaparsin in patients with relapsed or refractory peripheral T-cell lymphoma: results of an Asian phase 2 study

por Kim, Won-Seog, Fukuhara, Noriko, Yoon, Dok-Hyun, Yamamoto, Kazuhito, Uchida, Toshiki, Negoro, Eiju, Izutsu, Koji, Terui, Yasuhito, Nakajima, Hideaki, Ando, Kiyoshi, Suehiro, Youko, Kang, Hye Jin, Ko, Po-Shen, Nagahama, Fumiko, Sonehara, Yusuke, Nagai, Hirokazu, Tien, Hwei-Fang, Kwong, Yok-Lam, Tobinai, Kensei
Publicado 2023

Japanese subgroup analysis in the Asian phase II study of darinaparsin in patients with relapsed or refractory peripheral T-cell lymphoma

por Negoro, Eiju, Yamauchi, Takahiro, Fukuhara, Noriko, Yamamoto, Kazuhito, Uchida, Toshiki, Izutsu, Koji, Maruyama, Dai, Terui, Yasuhito, Nakajima, Hideaki, Ando, Kiyoshi, Suehiro, Youko, Choi, Ilseung, Kanemura, Nobuhiro, Nakamura, Nobuhiko, Yamamoto, Go, Maeda, Yoshinobu, Shibayama, Hirohiko, Nagahama, Fumiko, Sonehara, Yusuke, Nagai, Hirokazu, Tien, Hwei-Fang, Kwong, Yok-Lam, Kim, Won-Seog, Tobinai, Kensei
Publicado 2023